As you know, our safety-engineered syringe, reduces risk of needlestick injury, unsafe injection and getting a virus, thereby stopping disease transmission. In the process of getting things to the market, we wanted to put the right management in place.
Thus we have appointed a new president and CEO for LomMedical.
We tell you a bit about the process the board went through to choose our new CEO.
The Board of Directors is pleased to announce that the company has unanimously approved the appointment of Guy D. Reynolds to take over as President and CEO of L.O.M.
This is conditional on a successful capital raise due to close in April and subject to his existing contractual commitments.
The L. Board
Guy Reynolds is the Chairman and Non-executive Director for VCP Advisors Ltd and Chief Executive Officer of LOC, leaders in oncology care. LOC is part of HCA Healthcare UK (Hospital Corporation of America – HCA).
The LOC is a best in class cancer treatment business operating in 7 locations across the UK. In addition He was also appointed CEO for all of urology services across the entire group. Guy was a Board member of The Physicians Clinic and Vice President for all Cancer Services across HCA International.
Mr Guy Reynolds graduated from Oxford University, St Catherine’s College with a 2:1 Honours Degree in Jurisprudence and Qualified as a solicitor in the supreme courts of England and Wales Focussing on General Corporate Law, including Private Equity, ECM and M&A with Linklaters LLP.
Guy worked with Credit Suisse Securities (Europe) Limited, as an associate in the Equity Corporate Finance team and is an approved Person for the FSA (CISI 1 and 2).
Mr Reynolds experience also includes restructuring, IPO’s, rights issues and public and private M&A transactions.
I had the opportunity to ask Herb some questions (see below) about Guy’s appointment. I think his answers should interest you.
Herb, why did you and the board decide to look for a new President and CEO?
LomMedical has evolved in the medical device sector into a potentially significant entity. Because of this growth, it was important that the company stays current with the progress it has achieved.
We decided that L.O.M. needed a person with contacts both in the medical and finance sector. We also wanted an individual that brought experience in the medical industry to the table and had the necessary business acumen.
How did you go about finding the right fit for LOM?
We started our search last year. We used our contacts and social networks for spreading the word in the industry.
It took some time and effort, of course. Nevertheless, thanks to these efforts we ended up with a few qualified candidates.
Guy Reynolds brings an impressive résumé. But as importantly, he comes with a track record that is important to make sure that we continue executing our plans as timely as possible. What the board liked about Mr. Guy Reynolds’ candidacy was the importance he put upon keeping shareholders informed and in the loop.
Will you ride off into the sunset, Herb?
Nice thought, Debbie 🙂
No, as I pointed out in our video that we published early this year, there are a few things left for me to accomplish. Our smart syringe with sharps injury and reuse prevention still needs to get regulatory approval.
For instance, I will continue with L.O.M as the Chairman of the board. In this capacity, I will be working closely with Mr. Guy Reynolds and the L.O.M. team.
In our video I outlined our plans for 2018. There are a few important things we want to accomplish this year. Helping with these and focusing on strategy, will keep me busy. Moreover, Guy and I will have to plan and execute some future steps.
Join the discussion: Your opinion matters
Thanks to Herb for this interview.
All what is left for me to write down is that we like to hear from you what you think (#CEOsecrets) ?